Vancomycin-resistant enterococci: The clinical effect of a common nosocomial pathogen

Diagnostic Microbiology and Infectious Disease

Volumn 33, Issue 2, 1999, Pages 113-120

  Linden, Peter K ^a   Miller, Carole B ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; GENTAMICIN; GLYCOPEPTIDE; NITROFURANTOIN; NOVOBIOCIN; RIFAMPICIN; STREPTOGRAMIN DERIVATIVE; STREPTOMYCIN; TETRACYCLINE; TICARCILLIN; VANCOMYCIN;

ADULT; AGED; BACTEREMIA; CASE REPORT; CONFERENCE PAPER; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; HOSPITAL INFECTION; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; HUMANS; VANCOMYCIN;

EID: 0033042943     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00148-5     Document Type: Conference Paper

References (50)

1. Archer G., Auger P., Doern G., Ferraro M.J., Fuchs P.C., Joregensen J.H., Low D.E., Murray P.R., Reller L.B., Stratton C.W. RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis. 16:1993;223-226.
2. Boyce J.M., Opal S.M., Chow J.W., Zervos M.J., Potter-Bynoe G., Sherman C.B., Romulo R.L., Fortna S., Medeiros A.A. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 32:1994;1148.
3. Boyce J.M., Mermel L.A., Zervos M.J., Rice L.B., Potter-Bynoe G., Giorgio C., Medeiros A.A. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 16:1995;634-637.
4. Nosocomial enterococci resistant to vancomycin- United States 1989-1993. MMWR. 42:1993;597-599.
5. Chia J.K., Nakata M.M., Park S.S., Lewis R.P., McKee B. Use of bacitracin in therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 21:1995;1520.
6. Clark N.C., Cooksey R.C., Hill B.C., Swenson J.M., Tenover F.C. Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother. 37:1993;2311.
7. Dominguez E.A., David J.C., Langnas A.N., Winfield B., Cavilieri S.J., Rupp M.E. An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients. Liver Transplant Surg. 3:1997;586-590.
8. Edmond M.B., Ober J.F., Weinbaum D.L., Pfaller M.A., Hwang T., Sanford M.D., Wenzel R.P. Vancomycin-resistant Enterococcus faecium bacteremia Risk factors for infection . Clin Infect Dis. 20:1995;1126.
9. Evans M.E., Kortas K.G. Vancomycin use in a university medical center Comparison with hospital infection control practices advisory committee guidelines . Infect Control Hosp Epidemiol. 17:1996;356-359.
10. Furlong W.B., Rakowski T.A. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns. Clin Infect Dis. 25:1997;163-164.
11. Gould F.K., Freeman R. Nosocomial infection with microsphere beds. Lancet. 342:1993;241.
12. Handwerger S., Raucher B., Altarac D., Monka J., Marchione S., Singh K.V., Murray B.E., Wolff J., Walters B. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 16:1993;750.
13. Hoge C.W., Adams J., Buchanan B., Sears S.D. Enterococcal bacteremia to treat or not to treat, a reappraisal . Rev Infect Dis. 12:1991;600-605.
14. Howe R.A., Robson M., Oakhill A., Cornish J.M., Millar M.R. Successful use of tetracycline as therapy of an immunocompromised patients with septicaemia caused by a vancomycin-resistant enterococcus. J Antimicrob Chemother. 40:1997;144-145.
15. Johnson SV, Hoey LL, Vance-Bryan K (19195) Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention. Pharmacotherapy 15:579-585.
16. Jones R.N., Marshall S.A., Pfaller M.A., Wilke W.W., Hollis R.J., Erwin M.E., Edmond M.B., Wenzel R.P. Nosocomial enterococcal blood Stream infections in the SCOPE Program Antimicrobial resistance, species occurrence, molecular testing results and laboratory accuracy . Diagn Microbiol Infect Dis. 29:1997;95-102.
17. Jones R.N. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med. 100:(Suppl 6A):1996;3S-12S.
18. Lai K.K. Treatment of vancomycin-resistant Enterococcus faecium infections. Arch Intern Med. 156:1996;2579-2584.
19. Landman D., Quale J.M. Management of infections due to resistant enterococci A review of therapeutic options . J Antimicrob Chemother. 40:1997;161-170.
20. Landry S.L., Kaiser D.L., Wenzel R.P. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia A controlled study . Am J Infect Control. 17:1989;323-329.
21. Linden P.K., Pokrywka M., Krystofiak S., et al. The effect of ICU cohorting on the cross infection rates of vancomycin-resistant Enterococcus faecium. Crit Care Med. 22:1994;A228.
22. Linden P.K., Pasculle A.W., Manez R., Kramer D.J., Fung J.J., Pinna A.D., Kusne S. Differences in outcome for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis. 22:1996;663.
23. Linden P.K., Pasculle A.W., McDevitt D., Kramer D.J. Effect of quinupristin/dalfopristin on the outcome of vancomycin resistant Enterococcus faecium bacteremia Comparison with a control cohort . J Antimicrob Chemother. 39:(Suppl A):1997;145-151.
24. Livornese L.L., Dias S., Samel C., Romanowski B., Taylor S., May P., Pitsakis P., Woods G., Kaye D., Levison M.E. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 117:1992;112-116.
25. Lucas G.M., Lechtzin N., Wonder D., Yau L.L., Flexner C.W., Moore R.D. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia comparison of clinical features and outcomes . Clin Infect Dis. 26:1998;1127-1133.
26. Lynn W.A., Clutterbuck E., Want S., Markides V., Lacey S., Rogers T.R., Cohen J. Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin. Lancet. 344:1994;1025-1026.
27. Mainous M.R., Lipsett P.A., O'Brien M. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? Arch Surg. 1997;132:1997;76-81.
28. Mato R., deLencastre H., Roberts R.B., Tomasz A. Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City Hospital. Microb Drug Resist. 2:1996;309.
29. Moellering RC, Linden P (1996) Early clinical results of RP 59500 in bacteremia. Program and Abstracts of the Third International Conference on Macrolides, Azalides, and Streptogramins: Lisbon, Portugal; January, 1996.
30. Montecalvo M.A., Horowitz H., Wormser G.P., Seiter K., Carbonaro C.A. Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 39:1995;794.
31. Montecalvo M.A., Shay D.K., Patel P., Tacsa L., Maloney S.A., Jarvis W.R., Wormser G.P. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med. 156:1996;1458-1462.
32. Nachtman A., Verma R., Egnor M. Vancomycin-resistant Enterococcus faecium shunt infection in an infant An antibiotic cure . Microb Drug Resist. 1:1995;95-96.
33. Newell K.A., Millis J.M., Arnow P.M., et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation. 15:1998;439-442.
34. Norris A.H., Reilly J., Edelstein P.H., Brennan P.J., Schuster M.G. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis. 20:1995;1137-1144.
35. Noskin G.A., Till M., Patterson B.K., Clarke J.T., Warren J.R. High-level gentamicin resistance in Enterococcus faecalis bacteremia. J Infect Dis. 164:1991;1212-1215.
36. Noskin G.A., Peterson L.R., Warren J.R. Enterococcus faecium and Enterococcus faecalis bacteremia. Clin Infect Dis. 20:1995;296-301.
37. Noskin G.A., Stosor V., Cooper I., Peterson L.R. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol. 16:1995;577-581.
38. Papanicolaou G.A., Meyers B.R., Meyers J., Mendelson M.H., Emre L.W., Sheiner P., Miller C. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients Risk factors of acquisition and mortality . Clin Infect Dis. 23:1996;760-766.
39. Quale J., Landman D., Saurina G., Atwood E., DiTore V., Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis. 23:1996;1020-1025.
40. Rubin L.G., Tucci V., Cercenado E., Eliopoulos G., Isenberg H.D. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 13:1992;700.
41. Ruoff K.L., de la Maza L., Murtagh M.J., Spargo J.D., Ferraro M.J. Species identification of enterococci isolated from clinical specimens. J Clin Microbiol. 28:(3):1990;435-437.
42. Sahgal V.S., Urban C., Mariano N., Weinbaum F., Turner J., Rahal J.J. Quinupristin/dalfopristin therapy for vancomycin-resistant Enterococcus faecium aortic graft infection Case report . Microbial Drug Resistance. 1:1995;245-247.
43. Shay D.K., Maloney S.A., Montecalvo M., Banerjee S., Wormser G.P., Arduino M.J., Bland L.A., Jarvis W.R. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 172:1995;993-1000.
44. Shlaes D.M., Gerding D.N., John J.F., et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol. 18:1997;275-291.
45. Slaughter S., Hayden M.K., Nathan C., Hu T.C., Rice T., Van Voorhis J., Matushek M., Franklin C., Weinstein R.A. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med. 1125:1996;448-456.
46. Stroud L., Edwards J., Danzig L., Culver D., Gaynes R. Risk factors for mortality with enterococcal bloodstream infections. Infect Control Hosp Epidemiol. 17:1996;576-580.
47. Troidle L., Kliger A.S., Gorban-Brennan N., Fikrig M., Golden M., Finkelstein F.O. Nine episodes of CPD-peritonitis with vancomycin-resistant enterococci. Kidney Int. 50:1996;68-72.
48. Van der Auwera P., Pensart N., Korten V., Murray B.E., Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers selection of highly glycopeptide-resistant enterococci . J Infect Dis. 173:1996;1129-1136.
49. Watanakunakorn C., Patel R. Comparison of patients with enterococcal bacteremia due to strains with and without high level gentamicin resistance. Clin Infect Dis. 17:1993;74-78.
50. Yamaguchi E., Valena F., Smith S.M., Simmons A., Eng R.H.K. Colonization pattern of vancomycin-resistant Enterococcus faecium. Am J Infect Control. 22:1994;202-206.